Correlation Between Catalyst Pharmaceuticals and Loews Corp

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Loews Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Loews Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Loews Corp, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Loews Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Loews Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Loews Corp.

Diversification Opportunities for Catalyst Pharmaceuticals and Loews Corp

0.08

Correlation Coefficient

Catalyst Pharmaceuticals  Loews Corp

Significant diversification

The 3 months correlation between Catalyst and Loews is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Loews Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Loews Corp and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Loews Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Loews Corp has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Loews Corp go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Loews Corp

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.18 times more return on investment than Loews Corp. However, Catalyst Pharmaceuticals is 2.18 times more volatile than Loews Corp. It trades about 0.05 of its potential returns per unit of risk. Loews Corp is currently generating about 0.06 per unit of risk. If you would invest  2,141  in Catalyst Pharmaceuticals on October 24, 2024 and sell it today you would earn a total of  146.00  from holding Catalyst Pharmaceuticals or generate 6.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Loews Corp

Catalyst Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Loews Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Loews Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, Loews Corp is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Catalyst Pharmaceuticals and Loews Corp

The main advantage of trading using opposite Catalyst Pharmaceuticals and Loews Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Loews Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loews Corp will offset losses from the drop in Loews Corp's long position.

The idea behind Catalyst Pharmaceuticals and Loews Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.